Abstract:The human UBR5 (also known as EDD) is a single polypeptide chain HECT-type E3 ubiquitin ligase essential for embryonic development in mammals. Although widely expressed, UBR5 is markedly amplified and overexpressed in breast, ovarian, prostate, gastric and pancreatic cancers. Dysregulated UBR5 functions like an oncoprotein to promote cancer growth and metastasis, making UBR5 a potential target for therapeutics. Unexpectedly, we found that human UBR5 assembles a dimer and a tetramer in solution. We determined the dimer structure at 2.8 [A] and the tetramer structure at 3.5 [A] average resolution. UBR5 is a crescent shaped molecule with a seven-bladed {beta}-propeller and two small {beta}-barrel domains (SBB1/2) at the N-terminal region, a catalytic HECT domain at the C-terminus, and an extended helical scaffold and an N-degron-recognizing UBR box in the middle. The dimer is assembled as a stable head-to-tail dimer via extensive interactions in the middle helical scaffold region. The tetramer is assembled via SBB2-SBB2 interaction from two face-to-face dimers, forming a large cage with all four catalytic HECT domains facing the central cavity. Importantly, the N-terminal region of one subunit and the HECT of the other form an intermolecular jaw in the dimer. Using enzymatic and cellular assays, we showed that the jaw-lining residues are important for function, suggesting that the intermolar jaw functions to recruit ubiquitin loaded E2 to UBR5 for the transthiolation reaction. Further work is needed to understand how oligomerization regulates the UBR5 ligase activity. This work provides a framework for structure-based anticancer drug development against the distinctive HECT E3 ligase and contributes to a growing appreciation of E3 ligase diversity.

A Tunable Brake for HECT Ubiquitin Ligases.

A multi-lock inhibitory mechanism for fine-tuning enzyme activities of the HECT family E3 ligases

Comparative analysis of the catalytic regulation of NEDD4-1 and WWP2 ubiquitin ligases

Protein semisynthesis reveals plasticity in HECT E3 ubiquitin ligase mechanisms

Reconstitution and Structural Analysis of a HECT Ligase-Ubiquitin Complex via an Activity-Based Probe

Oligomerization-primed Coiled-Coil Domain Interaction with Ubc13 Confers Processivity to TRAF6 Ubiquitin Ligase Activity.

Targeting UBE2C for Degradation by Bioprotacs Based on Bacterial E3 Ligase

Structural mechanisms of autoinhibition and substrate recognition by the ubiquitin ligase HACE1

Structure of the human UBR5 E3 ubiquitin ligase

Molecular determinants of polyubiquitin linkage selection by an HECT ubiquitin ligase

Structural ubiquitin contributes to K48 linkage-specificity of the HECT ligase Tom1

The E3 ligase HUWE1 interacts with ubiquitin non‐covalently via key residues in the HECT domain

HUWE1 employs a giant substrate-binding ring to feed and regulate its HECT E3 domain

Mechanistic insights into the enzymatic activity of E3 ligase HOIL-1L and its regulation by the linear ubiquitin chain binding

Feedback regulation of ubiquitination and phase separation of HECT E3 ligases

Pten Regulation by Wwp2

New Discoveries on the Roles of “Other” HECT E3 Ubiquitin Ligases in Disease Development

The role of E3 ubiquitin ligase HECTD3 in cancer and beyond

A ligand discovery toolbox for the WWE domain family of human E3 ligases

Exploration of bromodomain ligand-linker conjugation sites for efficient CBP/p300 heterobifunctional degrader activity

Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy